SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-17-176713
Filing Date
2017-05-19
Accepted
2017-05-19 16:36:05
Documents
10
Period of Report
2017-05-19

Document Format Files

Seq Description Document Type Size
1 6-K d350177d6k.htm 6-K 12013
2 EX-99.1 d350177dex991.htm EX-99.1 6933
3 EX-99.2 d350177dex992.htm EX-99.2 14521
4 EX-99.3 d350177dex993.htm EX-99.3 602814
5 EX-99.4 d350177dex994.htm EX-99.4 12927
6 GRAPHIC g350177ex994pg01.jpg GRAPHIC 155553
7 GRAPHIC g350177ex994pg02.jpg GRAPHIC 121303
8 GRAPHIC g350177g01m43.jpg GRAPHIC 65847
9 GRAPHIC g350177g07r64.jpg GRAPHIC 36526
10 GRAPHIC g350177g91w75.jpg GRAPHIC 36776
  Complete submission text file 0001193125-17-176713.txt   1223688
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 17858390
SIC: 2834 Pharmaceutical Preparations